| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Shashi Sharma | |
| Bal Ram Singh | |||
| Shuowei Cai | |||
| P2860 | cites work | Botulinal neurotoxins: revival of an old killer | Q23832313 |
| Botulinum Toxin as a Biological Weapon: Medical and Public Health Management | Q23832736 | ||
| Botulinum neurotoxin detection and differentiation by mass spectrometry | Q24612537 | ||
| Microcoding: the second step in DNA barcoding | Q24673750 | ||
| Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin | Q29619130 | ||
| Multiplexed particle-based flow cytometric assays | Q30925110 | ||
| From the mouse to the mass spectrometer: detection and differentiation of the endoproteinase activities of botulinum neurotoxins A-G by mass spectrometry | Q33218186 | ||
| Detection of botulinum neurotoxin A in a spiked milk sample with subtype identification through toxin proteomics | Q33224227 | ||
| RNA aptamers as reversible antagonists of coagulation factor IXa. | Q33344114 | ||
| Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease | Q33850134 | ||
| Analyzing a bioterror attack on the food supply: the case of botulinum toxin in milk | Q33871288 | ||
| Evaluation of lateral-flow Clostridium botulinum neurotoxin detection kits for food analysis | Q33884560 | ||
| Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization | Q34034156 | ||
| Combining nucleic acid amplification and detection | Q34134912 | ||
| Foodborne botulism in the United States, 1990-2000 | Q34361019 | ||
| Clostridium botulinum and its neurotoxins: a metabolic and cellular perspective | Q34398278 | ||
| Human botulism immune globulin for the treatment of infant botulism | Q34490632 | ||
| Immuno-PCR: very sensitive antigen detection by means of specific antibody-DNA conjugates | Q34541703 | ||
| Microbiological, biological, and chemical weapons of warfare and terrorism | Q34695957 | ||
| Protein chip technology | Q35053334 | ||
| Array biosensor for detection of toxins | Q35156540 | ||
| Methods and applications of antibody microarrays in cancer research | Q35574629 | ||
| Identification of the major steps in botulinum toxin action | Q35639122 | ||
| Protein microarrays in diagnosing IgE-mediated diseases: spotting allergy at the molecular level | Q35821849 | ||
| Presynaptic receptor arrays for clostridial neurotoxins. | Q35894120 | ||
| Molecular beacons | Q35902775 | ||
| Immuno-PCR: high sensitivity detection of proteins by nucleic acid amplification. | Q36076154 | ||
| Internalization and mechanism of action of clostridial toxins in neurons | Q36144675 | ||
| Methods for detection of Clostridium botulinum toxin in foods | Q36162286 | ||
| Applications of Luminex xMAP technology for rapid, high-throughput multiplexed nucleic acid detection | Q36231307 | ||
| Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells | Q36325534 | ||
| Adult botulism type F in the United States, 1981-2002. | Q36339545 | ||
| Botulinum neurotoxin structure, engineering, and novel cellular trafficking and targeting | Q36511574 | ||
| High-resolution molecular discrimination by RNA. | Q36674176 | ||
| Immunoassays with rolling circle DNA amplification: a versatile platform for ultrasensitive antigen detection | Q37411585 | ||
| Using fluorescent sensors to detect botulinum neurotoxin activity in vitro and in living cells | Q37570865 | ||
| Botulinum neurotoxin type G proteolyses the Ala81-Ala82 bond of rat synaptobrevin 2. | Q38308843 | ||
| Detection of oncoprotein platelet-derived growth factor using a fluorescent signaling complex of an aptamer and TOTO. | Q38316297 | ||
| Nanoparticle-based bio-bar codes for the ultrasensitive detection of proteins | Q38349918 | ||
| Infant botulism. Identification of Clostridium botulinum and its toxins in faeces | Q39405144 | ||
| SV2 is the protein receptor for botulinum neurotoxin A. | Q40303506 | ||
| Biotechnology offers revolution to fish health management. | Q40339426 | ||
| A multiplex DNA suspension microarray for simultaneous detection and differentiation of classical swine fever virus and other pestiviruses. | Q40479394 | ||
| Clostridium botulinum neurotoxins act with a wide range of potencies on SH-SY5Y human neuroblastoma cells | Q40777912 | ||
| Mutation detection and single-molecule counting using isothermal rolling-circle amplification | Q41025766 | ||
| Structure and function of tetanus and botulinum neurotoxins. | Q41082871 | ||
| Biosensor detection of botulinum toxoid A and staphylococcal enterotoxin B in food | Q41820454 | ||
| Detection of type A, B, E, and F Clostridium botulinum neurotoxins in foods by using an amplified enzyme-linked immunosorbent assay with digoxigenin-labeled antibodies | Q41907289 | ||
| Differential roles of developmentally distinct SNAP-25 isoforms in the neurotransmitter release process | Q43691601 | ||
| High-throughput assays for botulinum neurotoxin proteolytic activity: serotypes A, B, D, and F. | Q43718011 | ||
| Detection of Clostridium botulinum toxin A using a fiber optic-based biosensor | Q44199943 | ||
| Synaptotagmins I and II act as nerve cell receptors for botulinum neurotoxin G. | Q44881077 | ||
| Primary cell culture for evaluation of botulinum neurotoxin antagonists | Q45246223 | ||
| Botulinum neurotoxin C1 cleaves both syntaxin and SNAP-25 in intact and permeabilized chromaffin cells: correlation with its blockade of catecholamine release | Q45345428 | ||
| Translocation of botulinum neurotoxin light chain protease through the heavy chain channel | Q46942366 | ||
| Clostridium botulinum: an increasing complication of heroin misuse | Q47724665 | ||
| Enhancement of the endopeptidase activity of botulinum neurotoxin by its associated proteins and dithiothreitol | Q48199572 | ||
| Botulinum neurotoxin type C cleaves a single Lys-Ala bond within the carboxyl-terminal region of syntaxins | Q49164892 | ||
| Analysis of terbuthylazine in soil samples by two test strip immunoassay formats using reflectance and luminescence detection. | Q50515171 | ||
| Quantum dot-based multiplexed fluorescence resonance energy transfer. | Q51301335 | ||
| A comparability study of the emerging protein array platforms with established ELISA procedures. | Q51413873 | ||
| A bio-barcode assay for on-chip attomolar-sensitivity protein detection. | Q51583098 | ||
| Ganglioside?liposome immunoassay for the detection of botulinum toxin | Q51644040 | ||
| Bio-bar-code-based DNA detection with PCR-like sensitivity. | Q51676074 | ||
| Multiplexed toxin analysis using four colors of quantum dot fluororeagents. | Q51717792 | ||
| A mathematical model of lateral flow bioreactions applied to sandwich assays. | Q51725821 | ||
| Botulism and botulism-like illness in chronic drug abusers. | Q51827544 | ||
| Uptake of botulinum neurotoxin into cultured neurons. | Q52095157 | ||
| The high-affinity binding of Clostridium botulinum type B neurotoxin to synaptotagmin II associated with gangliosides GT1b/GD1a. | Q52312776 | ||
| The 5th International Conference on Basic and Therapeutic Aspects of Botulinum and Tetanus Neurotoxins. Workshop review: assays and detection. | Q53253916 | ||
| Detection of Clostridium botulinum neurotoxin type A using immuno-PCR. | Q53957217 | ||
| How do tetanus and botulinum toxins bind to neuronal membranes? | Q56226691 | ||
| Type A and B Neurotoxin Genes in a Clostridium botulinum Type AB Strain | Q57064477 | ||
| Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25 | Q57979097 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 109-125 | |
| P577 | publication date | 2007-04-01 | |
| P1433 | published in | Critical Reviews in Microbiology | Q5186671 |
| P1476 | title | Botulism diagnostics: from clinical symptoms to in vitro assays | |
| P478 | volume | 33 |
| Q40104099 | A Novel Surface Plasmon Resonance Biosensor for the Rapid Detection of Botulinum Neurotoxins |
| Q35303805 | A two-stage multiplex method for quantitative analysis of botulinum neurotoxins type A, B, E, and F by MALDI-TOF mass spectrometry |
| Q90001391 | Alternative Methods for Testing Botulinum Toxin: Current Status and Future Perspectives |
| Q47315182 | An in vitro cell-based potency assay for pharmaceutical type A botulinum antitoxins |
| Q37355925 | Antibody protection against botulinum neurotoxin intoxication in mice |
| Q40132718 | Bioluminescence assay for the highly sensitive detection of botulinum neurotoxin A activity |
| Q55462919 | Botulinum Neurotoxin Detection Methods for Public Health Response and Surveillance. |
| Q38016960 | Botulinum neurotoxin: where are we with detection technologies? |
| Q37822447 | Botulism, where are we now? |
| Q43187079 | Bowel loops and eyelid droops |
| Q35001291 | Centrifugal microfluidic platform for ultrasensitive detection of botulinum toxin. |
| Q37264589 | Characterization of botulinum neurotoxin A subtypes 1 through 5 by investigation of activities in mice, in neuronal cell cultures, and in vitro |
| Q42607102 | Comparative immunochemical characteristics of botulinum neurotoxin type A and its associated proteins |
| Q35230342 | Creating and virtually screening databases of fluorescently-labelled compounds for the discovery of target-specific molecular probes. |
| Q38034159 | Current development of microfluidic immunosensing approaches for mycotoxin detection via capillary electromigration and lateral flow technology |
| Q36361811 | Detection of botulinum neurotoxin serotype A, B, and F proteolytic activity in complex matrices with picomolar to femtomolar sensitivity |
| Q43125124 | Development of a multiplex Endopep-MS assay for simultaneous detection of botulinum toxins A, B and E. |
| Q38388175 | Development of immunodetection system for botulinum neurotoxin type B using synthetic gene based recombinant protein. |
| Q37333630 | Genetic characterization of Clostridium botulinum associated with type B infant botulism in Japan |
| Q34423232 | Improved detection of botulinum neurotoxin serotype A by Endopep-MS through peptide substrate modification |
| Q35530703 | In vitro detection and quantification of botulinum neurotoxin type e activity in avian blood |
| Q33513499 | Lab-on-a-chip for botulinum neurotoxin a (BoNT-A) activity analysis |
| Q37038616 | Molecular basis of activation of endopeptidase activity of botulinum neurotoxin type E. |
| Q41831799 | Nanopore sensing of botulinum toxin type B by discriminating an enzymatically cleaved Peptide from a synaptic protein synaptobrevin 2 derivative |
| Q58615372 | Natural Compounds and their Analogues as Potent Antidotes against the Most Poisonous Bacterial toxin |
| Q35941093 | Neurotoxin gene profiling of clostridium botulinum types C and D native to different countries within Europe |
| Q35839545 | Novel application of human neurons derived from induced pluripotent stem cells for highly sensitive botulinum neurotoxin detection |
| Q64070069 | Point-of-Need DNA Testing for Detection of Foodborne Pathogenic Bacteria |
| Q54263961 | Proteomic Methods of Detection and Quantification of Protein Toxins. |
| Q91994510 | Rapid Detection of Botulinum Neurotoxins-A Review |
| Q42040084 | Rapid Microfluidic Assay for the Detection of Botulinum Neurotoxin in Animal Sera |
| Q38292816 | Selection of RNA Aptamers Against Botulinum Neurotoxin Type A Light Chain Through a Non-Radioactive Approach |
| Q35506757 | Sensing the deadliest toxin: technologies for botulinum neurotoxin detection |
| Q58644766 | Serum False-Positive Botulism in Guillain-Barré Syndrome |
| Q36482732 | Sheep monoclonal antibodies prevent systemic effects of botulinum neurotoxin A1 |
| Q41636038 | Toxin detection in patients' sera by mass spectrometry during two outbreaks of type A Botulism in France. |
| Q36401431 | Use of Monoclonal Antibodies in the Sensitive Detection and Neutralization of Botulinum Neurotoxin Serotype B. |
Search more.